NDI Medical, a US-based medical device incubator set up in 2002, has started an $8m healthcare commercialization fund focused on people’s nerves.
A quarter of the money came from the Ohio state and the rest from undisclosed investors.
Last year, the company sold its first product, a bladder pacing device called MedStim, to medical device maker Medtronic for $42m.
NDI also spun out two more technologies: Checkpoint Surgical, which is developing a disposable product to identify nerve and muscle function during surgery; and SPR Therapeutics, a nerve-stimulating device that relieves chronic pain, such as in the shoulder or lower back.